Biolase Technology, Inc.
4 Cromwell
Irvine,
CA 92618
United States - Map
Phone: 949-361-1200
Fax: 949-366-3325
Web Site: http://www.biolase.com
| BIOLASE Technology, Inc., a medical technology company, develops, manufactures, and markets lasers and related products and services focused on technologies for applications and procedures in dentistry and medicine. It offers Waterlase systems, a combination of water and laser to perform dental procedures to cut soft and hard tissue plus bone; and Diode systems that use a semiconductor diode laser to perform soft tissue and cosmetic procedures, including teeth whitening. The company also provides related accessories and disposable products for its laser systems, which include disposable laser tips, flexible fibers, hand pieces, and tooth whitening gel kits. The companys products are used by general dentists, periodontists, endodontists, oral surgeons, and other dental specialists. It offers its products through direct sales and a network of independent distributors in the United States, Canada, Asia, Latin America, Europe, the Middle East, Africa, and the Pacific Rim countries. The company was formerly known as Societe Endo Technic, SA and changed its name to BIOLASE Technology, Inc. in 1994. BIOLASE Technology, Inc. was founded in 1984 and is headquartered in Irvine, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David M. M. Mulder , 47
Chief Exec. Officer, Director and Member of Secondary Stock Option Committee |
$
147.00K |
$
0 | Mr. Federico Pignatelli , 57
Chairman Emeritus and Pres |
$
140.00K |
$
0 | Mr. Frederick M. Capallo , 49
Interim Chief Financial Officer, Principal Accounting Officer, VP and Corp. Controller |
$
185.00K |
$
0 | Mr. Matthew J. Hunt ,
VP of Global Sales |
N/A
| N/A | Mr. Peter Rowland ,
VP of Asia Pacific Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.45% Nasdaq 
0.20%
Profile
